Ilex Medical Ltd (TLV: ILX)

Market Cap	721.51M
Revenue (ttm)	964.54M
Net Income (ttm)	50.74M
Shares Out	11.28M
EPS (ttm)	4.53
PE Ratio	14.13
Forward PE	n/a
Dividend	1.36 (2.13%)
Ex-Dividend Date	Apr 7, 2024

Volume	27
Open	6,170.00
Previous Close	6,170.00
Day's Range	6,170.00 - 6,430.00
52-Week Range	5,352.00 - 7,572.00
Beta	-0.09
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 25, 2024

About Ilex Medical

Ilex Medical Ltd provides healthcare technological solutions in Israel, South Africa, and internationally. The company offers microbiology, chemistry, molecular biology, immunochemistry, and blood banking solutions. It also offers coagulation, hematology, blood gases, bilirubin, biomarkers, fertility, cellular medicine occult blood, and calprotectin services, as well as provides LIS, urine microscopy, osmolarity, and genetic laboratory services. In addition, the company offers medical automation solutions for microbiology, immunoserology, chemi...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1977
• Employees: 223
• Stock Exchange: Tel Aviv Stock Exchange
• Ticker Symbol: ILX

Financial Performance

In 2023, Ilex Medical's revenue was 930.89 million, an increase of 6.69% compared to the previous year's 872.54 million. Earnings were 50.89 million, a decrease of -50.17%.